Prevalence and risk factors for impaired activities of daily living in patients with neo-vascular age-related macular degeneration who present for anti-VEGF treatment
Kim Van Vu, Paul Mitchell, Harshil Dharamdasani Detaram, George Burlutsky, Gerald Liew, Bamini Gopinath

TL;DR
This study finds that many patients with a specific type of eye disease have trouble with daily tasks, and factors like poor vision and mental health play a role.
Contribution
The study identifies key risk factors for impaired daily living in patients with neovascular age-related macular degeneration undergoing anti-VEGF treatment.
Findings
Over one-third of patients had impaired basic and total activities of daily living.
Moderate visual impairment and blindness significantly increased the odds of ADL impairment.
Better quality of life metrics were linked to reduced odds of ADL impairment.
Abstract
To assess the prevalence and correlates of impaired activities of daily living (ADLs) in patients with neovascular age-related macular degeneration (nAMD) who present for anti-vascular endothelial growth factor (VEGF) therapy. In a clinic-based cohort of 437 patients with nAMD who presented for anti-VEGF therapy, the Older American Resources and Services Scale (OARS) was administered to assess for impairments in basic, instrumental and total ADL. Logistic regression analyses were conducted to determine odds ratios (OR) and 95% confidence intervals (CI) for factors associated with ADL impairment. The prevalence of impaired basic, instrumental and total ADL was 37.76%, 67.82% and 39.59%, respectively. In multivariate-adjusted models, moderate visual impairment [OR 5.65, 95% CI (2.31–13.83) and blindness [OR 5.43, 95% CI (2.09–14.12)] were associated with greater odds of impaired total…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsRetinal Diseases and Treatments · Retinal Imaging and Analysis · Retinal and Optic Conditions
